Nurse Practitioner Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Heather Shoup

Nurse Practitioner, Gerontology Dayton, OH Nurse Practitioner

NPI 1407251523 CMS profile 10549884

2350 Miami Valley Dr Ste 500, Dayton, OH 45459

Open in the dashboard

General payments

$5,074

172 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Heather Shoup of Dayton, OH is reported in the CMS Open Payments database as having received $5,074 across 172 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 94th percentile of Nurse Practitioner, Gerontology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,146 30
2024 General $1,304 47
2023 General $1,043 35
2022 General $1,069 43
2021 General $512 17

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Heather Shoup
  • Nurse Practitioner, Gerontology median
  • Middle half of Nurse Practitioner, Gerontology
  • National median

In program year 2025, general payments to Heather Shoup were reported at $1,146. Among 4,139 Nurse Practitioner, Gerontology profiles paid that year, the median was $179 and the middle half received between $55 and $547.

Show as a table
Year Heather Shoup Nurse Practitioner, Gerontology median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $512 $133 $44–$396 $132
2022 $1,069 $142 $48–$452 $149
2023 $1,043 $158 $53–$482 $160
2024 $1,304 $171 $55–$533 $164
2025 $1,146 $179 $55–$547 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Janssen Biotech, Inc. $710 21 payments
  2. Ferring Pharmaceuticals Inc. $471 2 payments
  3. Bayer HealthCare Pharmaceuticals Inc. $413 14 payments
  4. Astellas Pharma US Inc $387 20 payments
  5. Teleflex LLC $298 3 payments
  6. Medtronic, Inc. $218 3 payments
  7. Sumitomo Pharma America, Inc. $202 11 payments
  8. AbbVie, Inc. $196 9 payments
  9. Urogen Pharma, Inc. $180 8 payments
  10. Dendreon Pharmaceuticals LLC $177 4 payments
  11. Other $1,823 77 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $4,214 166 payments
  2. Consulting Fee $450 1 payment
  3. Education $410 5 payments
Products named General payments · program years 2021–2025
  1. ERLEADA $710 21 payments
  2. ADSTILADRIN $471 2 payments
  3. Nubeqa $397 13 payments
  4. XTANDI $314 20 payments
  5. Xofigo $262 11 payments
  6. INTERSTIM $218 3 payments
  7. ORGOVYX $184 11 payments
  8. PROVENGE $177 4 payments
  9. MYRBETRIQ $166 10 payments
  10. JELMYTO $158 7 payments
  11. Other $2,342 90 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 26 drugs

Part D claims

1,831

Median for Nurse Practitioner: 389

Drug cost

$111,155

Median for Nurse Practitioner: $21,885

Branded share of claims

19.3%

Median for Nurse Practitioner: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Myrbetriq Mirabegron Brand 55 $56,614
Gemtesa Vibegron Brand 14 $15,881
Tamsulosin Hcl Generic 816 $12,112
Silodosin Generic 92 $9,503
Solifenacin Succinate Generic 25 $3,238
Potassium Citrate Er Potassium Citrate Brand 45 $2,950
Finasteride Generic 241 $2,449
Nitrofurantoin Nitrofurantoin Macrocrystal Brand 27 $1,354
Oxybutynin Chloride Er Oxybutynin Chloride Brand 38 $1,316
Dutasteride Generic 47 $923

The 10 drugs with the highest cost, of 26 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 229,976 Part D prescribers listed as Nurse Practitioner; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 22 billing codes

Paid by Medicare

$66,734

Of which drugs: $14,483

Medicare patients

544

Average age 76

Services billed

2,202

108 women, 436 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 47%
Cancer 36%
Ischemic heart disease 35%
Diabetes 33%
Chronic kidney disease 28%
Atrial fibrillation 24%
Heart failure 18%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Leuprolide acetate (for depot suspension), 7.5 mg J9217 Office 12 90 $12,559

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 17 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Nubeqa
  • Bayer HealthCare Pharmaceuticals Inc. $167
$167 — —
PYLARIFY
  • Progenics Pharmaceuticals, Inc. $146
$146 — —
ERLEADA
  • Janssen Biotech, Inc. $127
$127 — —
ORGOVYX
  • Sumitomo Pharma America, Inc. $72
  • PFIZER INC. $11
$83 — —
JELMYTO
  • UROGEN PHARMA, INC. $66
$66 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 17 in the dashboard with a free account

Records

172 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Nurse Practitioner, Gerontology in Ohio

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record